RIGHT TIME

The Inspire ANTI SNORING Implant is a medical device that is implanted into the body for the treating snoring and obstructive sleep apnea (OSA) syndrome.

Obstructive ANTI SNORING Syndrome

Obstructive sleep apnea syndrome is really a disease due to relapsing episodes of anti snoring. This is a condition where breathing stops for a lot more than 10 seconds, where oxygen saturation in the blood is reduced by a lot more than 4%.

OSA syndrome occurs during sleep, once the muscles of upper airways relax, evoking the obstruction of the respiratory tract. This leads to deterioration of blood oxygenation and provokes short unconscious wake-up episodes throughout the night. An unhealthy pattern of sleep places pressure on the body, causing increased blood circulation pressure and development of severe diseases. The diseases caused by OSA could be physical, such as hypertension, myocardium infarction and stroke. They might also be mental, including depression, chronic fatigue syndrome, loss of memory and concentration.

Before any treatment, a sleep study or a polysomnography is necessary. The polysomnography calculates the apnea index, that is the frequency of apnea episodes during 1 hour of sleep and determines the severe nature of the condition. The apnea index is considered significant if there are more than 20 apnea episodes per hour, whatever the presence or lack of clinical symptoms.

The gold standard of treatment for OSA syndrome is CPAP-therapy. However, CPAP therapy is not for everyone as many folks think it is uncomfortable to sleep with the mask on the facial skin and the device itself could be loud, especially since it commonly sits close to the head. Only 25% of patients may use CPAP-therapy for an extended period of time.

Therefore, recently Inspire Medical Systems Inc. has think of a very effective solution with the Inspire Sleep Apnea Implant.

How The Inspire Sleep Apnea Implant Works

The Inspire Sleep Apnea Implant is a battery operated device that promotes electrostimulation of the sublingual nerve. The battery life is approximately a decade.

The main unit of this device is placed under the skin, on the front right side of the chest and it monitors the phase of breathing. Another electrode is implanted for stimulation of the sublingual nerve, which creates muscle tension. This opens the upper airways and allows the tongue to stick out, and helps keep the airways open during sleep.

In addition to the two electrodes, this product also contains a handy small remote switch, which actually turns on these devices before sleep and switches it off once awake. This disables the electrodes from disturbing the processes of communication and eating through the active phase of your day, whenever a person needs physiological narrowing of the larynx and tongue movements for these procedures.

The individual may feel light involuntary contractions of the larynx, or tongue movements during initial usage of the device. These movements usually do not cause pain, instead only a minor discomfort. These unpleasant effects disappear after the first few uses of the device.

Generally, the implant should be checked one or two 2 times per year. However, based on the situation, an Inspire therapy-trained doctor may consult patients pretty much often.

The Inspire Sleep Apnea Implant is only ideal for:

Patients who are a lot more than 22 years old.
Patients who have been diagnosed with moderate or severe obstructive sleep apnea syndrome.
Patients having an apnea index in the range of 20 to 65.
Patients who are not comfortable with using CPAP therapy or didn’t work.
Patients with a body mass index of less than 32.
Body mass index (BMI) = weight (kg) / height^2 (m2).
A person with a weight of 80 kg and a height of 170 cm has

BMI = 80kg / (1.7m ^ 2) = 80 / 2.89 = 27.68 kg/ m2

The Inspire ANTI SNORING Implant could potentially replace CPAP therapy as ‘the gold standard’ of treatment for obstructive sleep apnea syndrome. A report by Dr. Ryan J. et al. shows that after implantation of the Inspire Sleep Apnea Implant, snoring is greatly decreased. A share of “no” or “soft” snoring changed from 22% at start of the treatment to 88% at 12 months and 91% at 24 months after the treatment. Also, the apnea index was reduced from 31 to 14. 82% of the patients in the analysis reported a nightly use of this therapy for five years. Therefore, it is evident that this method is highly effective and simple to use! ufabet